Hokkaido University · Institute for Genetic Medicine · 講師

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma‐Initiating Cells via the Canonical NF‐кB Pathway2026 · Cancer Science, 2026年04月27日
• Corrigendum to "Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction" [Metabolism 168 (2025) 156235].2025 · Metabolism: clinical and experimental, 170, 156299, 156299, 2025年09月,
• Metabolic Regulation by the Hypothalamic Neuropeptide, Gonadotropin-Inhibitory Hormone at Both the Central and Peripheral Levels2025 · Cells, 14, 4, 267, MDPI AG, 2025年02月12日,
• EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.2025 · Neuro-oncology, 27, 3, 682, 694, 2025年03月07日,

• 肥満による代謝異常発症の新たな分子メカニズムの解明
• 網膜光受容体メラノプシンの遺伝子破壊が代謝異常を招く分子メカニズム
• 甲状腺ホルモンによる生殖制御におけるＧｎＩＨシステムの作用機構
• 褐色脂肪特異的に発現する細胞表面分子Eva1の機能解析

• Official profile